Detroit Metro Times: “Rogers’ current plan reflects pharmaceutical industry priorities and places comparatively few new requirements on drug manufacturers.”

Detroit Metro Times: “Rogers’ approach warrants attention because he has spent years opposing government efforts to limit drug prices.”

LANSING — New reporting from Detroit Metro Times reveals corrupt multimillionaire Mike Rogers’ so-called healthcare plan “reflects pharmaceutical industry priorities,” includes proposals that “already exist” under federal law, and provides “few details” about how his proposals would actually lower healthcare costs for Michiganders. The report also reveals new details about Rogers’ toxic record of serving his Big Pharma donors, including how he used industry-aligned talking points in Congress to oppose measures that would lower prescription drug costs for veterans—which Rogers argued would be “harmful to innovation.”

The report found Rogers’ so-called healthcare plan includes “few details,” duplicates existing transparency measures already required by federal law, and “exclude[s] prescription drugs” from similar regulations already applied to hospitals and insurers.

• [S]everal of its central disclosure requirements already exist, and the proposal leaves unanswered how much further Rogers would go to protect patients.

• Hospitals have been required to disclose prices, including negotiated rates, since 2021.

• Rogers also wants insurers to answer for excessive denials […] Federal rules already require some of that reporting.

• The plan leaves voters with few details about what new protections they would receive, how those protections would be enforced, or how much they could expect to save.

According to the Detroit Metro Times, Rogers’ healthcare plan “reflects pharmaceutical industry priorities” by placing “comparatively few new requirements on drug manufacturers.”

• His plan doesn’t call for direct caps on manufacturers’ prices or new disclosure requirements specifically for drugmakers.

• The focus on hospitals and insurers overlaps with priorities promoted by Pharmaceutical Research and Manufacturers of America, the drug industry’s leading lobbying group.

When asked by the Detroit Metro Times about how Rogers’ healthcare plan would expand on existing law, or why his approach matches Big Pharma’s lobbying priorities, Rogers’ campaign refused to answer.

• Rogers’ campaign defended his proposal in a written statement to Metro Times. […] The statement didn’t explain how [Rogers’] enforcement mechanisms would work or how the disclosure proposals would differ from existing requirements. 

• The campaign also declined to address concerns that Rogers’ current plan reflects pharmaceutical industry priorities and places comparatively few new requirements on drug manufacturers. 

The Detroit Metro Times’ investigation also found Rogers repeatedly used his Big Pharma donors’ talking points in Congress while he opposed measures to lower prescription drug costs for veterans, arguing that it would be “harmful to innovation.”

• In 2006, Rogers was one of just 30 House members to oppose a motion directing congressional negotiators to accept a Senate provision extending federal prescription drug discounts to TRICARE retail pharmacies. TRICARE provides health coverage to service members, military retirees, and their families.

• Supporters said the provision could save hundreds of millions of dollars annually by extending discounts already available through other military pharmacy programs to prescriptions filled at neighborhood pharmacies.

• A year later, Rogers objected to another provision extending federal price ceilings through TRICARE. He called it an “indirect” price control and argued that “price controls are also harmful to innovation.”

While Rogers continued opposing measures to lower prescription drug costs for veterans, the Detroit Metro Times found he received more than $100,000 from pharmaceutical companies who were suing to block the provisions from being implemented.

• Congress enacted the price ceiling despite [Rogers’] objections. In 2008, a pharmaceutical trade group, the Coalition for Common Sense in Government Procurement, sued to block provisions implementing it, arguing that rebates could cost drugmakers more than $500 million.

• A Metro Times review of archived membership lists and Federal Election Commission records found that seven pharmaceutical companies associated with the coalition had contributed a combined $108,000 to Rogers’ campaign and leadership political action committee by that year.

• Rogers continued opposing government drug-price negotiations. In 2011, he voted against a motion intended to preserve the ability of the departments of Defense, Veterans Affairs, and Health and Human Services to negotiate lower prescription prices.

The Detroit Metro Times also found that Rogers has received more than $1 million from the opioid industry and their lobbyists while he “used arguments advanced by the industry and pain advocacy groups” to advance legislation to loosen and expand access to dangerous opioids. 

• Rogers’ financial ties to the drug industry stretch back decades.

• A Metro Times review of campaign finance filings and lobbying disclosures found that his campaigns and political committees received more than $1.13 million through July 2026 from opioid manufacturers, distributors, and retailers; lobbyists representing opioid-related companies and trade groups; and two industry organizations.

• About $618,542 of that total came from individual contributions by 129 lobbyists representing opioid industry interests. Manufacturers, distributors, and retailers accounted for about $484,200, and two industry groups contributed $32,500.

• During his time in Congress, Rogers repeatedly promoted the National Pain Care Policy Act, which sought to expand pain research, physician education, and access to treatment. Parts of the proposal became law through the Affordable Care Act in 2010.

• Opioid manufacturers and industry-backed organizations supported the legislation. Rogers also used arguments advanced by the industry and pain advocacy groups, describing chronic pain as an undertreated national problem and expressing concern that doctors were too nervous to treat patients.

Read more:

Detroit Metro Times: Mike Rogers is selling a health care fix after years of voting the other way

###